| Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19 M Fagyas, A Kertész, IM Siket, V Bánhegyi, B Kracskó, A Szegedi, ... Geroscience 43, 19-29, 2021 | 27 | 2021 |
| Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans GÁ Fülöp, A Oláh, T Csipo, Á Kovács, R Pórszász, R Veress, B Horváth, ... Basic research in cardiology 116, 1-16, 2021 | 22 | 2021 |
| Human tissue angiotensin converting enzyme (ace) activity is regulated by genetic polymorphisms, posttranslational modifications, endogenous inhibitors and secretion in the … V Banhegyi, A Enyedi, GÁ Fülöp, A Oláh, IM Siket, C Varadi, K Bottyán, ... Cells 10 (7), 1708, 2021 | 20 | 2021 |
| Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients M Fagyas, V Bánhegyi, K Úri, A Enyedi, E Lizanecz, IS Mányiné, L Mártha, ... Geroscience 43, 2289-2304, 2021 | 19 | 2021 |
| Tenascin‐C aggravates ventricular dilatation and angiotensin‐converting enzyme activity after myocardial infarction in mice D Santer, F Nagel, IF Gonçalves, C Kaun, J Wojta, M Fagyas, M Krššák, ... ESC Heart Failure 7 (5), 2113-2122, 2020 | 18 | 2020 |
| Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy M Lódi, V Bánhegyi, B Bódi, A Gyöngyösi, Á Kovács, A Árokszállási, ... Journal of Translational Medicine 18, 1-18, 2020 | 7 | 2020 |
| A szív pozitív inotróp támogatása a miozin-aktivátor hatású omecamtiv mecarbil segítségével= Inotropic therapy with the myosin activator omecamtiv mecarbil L Nagy, I Gödény, P Nánási, Á Leskó, L Balogh, V Bánhegyi, B Bódi, ... Cardiologia Hungarica 47 (2), 145-152, 2017 | 2 | 2017 |
| Level of the SARS-CoV-2 receptor ACE2 is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19 M Fagyas, A Kertész, IS Mányiné, V Bánhegyi, B Kracskó, A Szegedi, ... | 1 | 2020 |
| P568 Old dogma, new aspects-Role of angiotensin converting enzymes in the cardiovascular continuum V Banhegyi, M Fagyas, I Manyine Siket, A Enyedi, K Bottyan, I Edes, ... Cardiovascular Research 114 (suppl_1), S139-S139, 2018 | | 2018 |
| P7. 11 Predictive Value of Endothel Dysfunction Assessed by flow Mediated Vasodilatation and Arterial Stiffness Parameteres in Thrombotic Events of Primary Antiphospholipid … A Dioszegi, K Veres, B Kovacs, V Banhegyi, P Soltesz Artery Research 12 (1), 32-32, 2015 | | 2015 |
| Szöveti-és keringő angiotenzin konvertáló enzimek szabályozása kardiovaszkuláris megbetegedésekben B Viktor | | |
| Régi ismerős egy új köntösben: hol termelődik tulajdonképpen az ACE? V Bánhegyi, M Fagyas, I Mányiné Siket, A Enyedi, I Takács, T Végh, ... | | |
Zoltán PappUniversity of Debrecen, Department of Cardiology, Division of Clinical PhysiologyVerified email at med.unideb.hu
